Lung cancer resections in the general thoracic surgery portion of the STS database were analyzed. Although patients had multiple comorbidities, the length of stay was shorter and mortality was lower than in reports from other large databases.
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Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output Robert James Cerfolio, MD, FACS, FCCP, and Ayesha S. Bryant, MSPH, MD, Birmingham, Ala Chest tubes can be removed with up to 450 mL/day of drainage after pulmonary resection. An even higher volume might be accepted. Readmission resulting from a recurrent effusion is extremely uncommon, and the practice of leaving in a chest tube longer for drainage less than 450 mL/day is unsupported in the literature.
Surgery for Acquired
Cardiovascular Disease (ACD) 274 Durability of mitral valve repair in Barlow disease versus fibroelastic deficiency Willem Flameng, MD, PhD, Bart Meuris, MD, PhD, Paul Herijgers, MD, PhD, and Marie-Christine Herregods, MD, PhD, Leuven, Belgium
After valvuloplasty in 348 consecutive patients, the linearized recurrence rate of MR(..2/4) was 6.0% per year in Barlow disease and 2.9% in fibroelastic degeneration (P 5 .01). This rate could partially be explained by the use of chordal shortening, the nonuse of an annuloplasty ring, and the nonuse of a sliding plasty. When these techniques were avoided, the residual recurrence rate remained 2.9% in Barlow disease and 2.2% in fibroelastic deficiency (P . .05), which seems related to progression of valve degeneration.
283
Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function In a large animal model of myocardial dysfunction, molecular pathways underlying transmyocardial laser revascularization were evaluated, demonstrating significant increases in vasculogenesis, perfusion, and viability after transmyocardial laser revascularization. Regional contractility was significantly improved with transmyocardial laser revascularization. Among 858 repairs of extensive thoracoabdominal aneurysms, paraplegia developed in 10 patients within 48 hours postoperatively, despite intact intraoperative somatosensory evoked potentials. When compared with matched control subjects, paraplegic patients had higher venous pressures (P 5 .03) and lower mean aortic pressures (as a percentage of antecedent preoperative pressures, P 5 .03). Perhaps optimal hemodynamics in the early postoperative period can avert delayed paraplegia in some cases. Thirty consecutive patients with ventriculoarterial discordance, ventricular septal defect, and pulmonary stenosis underwent double root translocation, modified Nikaidoh (n 5 11), modified REV (n 5 7), and Rastelli (n 5 12) procedures. The hemodynamic performance of the reconstructed biventricular outflow tract, the early-term clinical outcomes, and the follow-up results were compared.
Surgery for Congenital
(continued on page 17A) We studied the relationship of continuous hematocrit levels at the onset of low-flow CPB in infant heart surgery to perioperative and 1-year developmental outcomes. Higher hematocrit levels are associated with better PDI scores and, marginally, to lower serum lactate levels. It may be appropriate to target hematocrit levels above 24%.
Predictors affecting durability of epicardial pacemaker leads in pediatric patients
Hiroomi Murayama, MD, Masanobu Maeda, MD, Hajime Sakurai, MD, Akihiko Usui, MD, and Yuichi Ueda, MD, Nagoya, Japan
Epicardial lead durability and risk factors for lead failure were retrospectively analyzed in pediatric epicardial pacing therapy. The overall 1-, 5-, 10-, and 15-year lead survival was 100%, 89.0%, 72.5%, and 55.5%, respectively. Multivariate Cox analysis revealed concurrent structural heart disease to be the only significant predictor of lead failure.
(continued on page 18A) The treatment of multivessel coronary artery disease with the simultaneous hybrid procedure, a minimally invasive technique for revascularization, provides for clinical outcomes and patient satisfaction that are very competitive with those of traditional off-pump coronary artery bypass. In addition, local activation of inflammation and coagulation is minimized, perhaps because of less myocardial manipulation and regional bouts of warm ischemia.
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Percutaneous mitral annuloplasty through the coronary sinus: An anatomic point of view :
Emmanuel Lansac, MD, Isabelle Di Centa, MD, Nawwar Al Attar, MD, David Messika-Zeitoun, MD, Richard Raffoul, MD, Alec Vahanian, MD, and Patrick Nataf, MD, Paris and Boulogne-Billancourt, France
The anatomic basis of percutaneous mitral annuloplasty through the coronary sinus was studied in cadaver hearts. The coronary sinus is distant from the mitral annulus up to 20 mm. Percutaneous annuloplasty achieves at best a commissure-to-commissure annuloplasty. The potential risk for impingement of the circumflex artery exists in 45.5% of cases. This report reviews our experience with extracorporeal membrane oxygenation over the years with respect to early and midterm outcome, as well as predictors of survival. Early indication, alternative peripheral cannulation techniques, and reduced anticoagulation to avoid perioperative bleeding could improve our results with increasing experience. Intraperitoneal seeding of a bioprosthetic heart valve as a tissue-engineering paradigm resulted in recellularization of a functional heart valve. Long-term follow-up showed an increased amount of regurgitation because the obtained contractile cells thickened and shortened the valve. Decreased, yet still appropriate, biomechanical properties were also observed.
405
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery Age 65 years and older is generally considered a contraindication to lung transplantation. This study sought to compare the outcome of lung transplantation in older patients versus that in a younger matched cohort. This report demonstrates that lung transplantation can be performed in select patients older than 65 years with acceptable clinical outcomes.
421
The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: 
